UnitedHealth’s Expansion and Payer Market Shifts with Jakob Emerson

Summary

---

Becker’s Healthcare Podcast – Episode Summary

Episode Title: UnitedHealth’s Expansion and Payer Market Shifts with Jakob Emerson
Date: August 21, 2025
Host: Scott Becker
Guest: Jakob Emerson, Journalist & Payer Industry Expert

---

Overview: Main Theme and Purpose

This episode dives into UnitedHealth's ongoing acquisitive growth, the shifting dynamics in the payer market, and how large national players are influencing U.S. healthcare. Jakob Emerson, known for his deep industry coverage, shares recent developments, key acquisitions, and what these changes mean for health systems, competitors, and investor confidence.

---

Key Discussion Points and Insights

1. Health System-Owned Plans and Medicare Advantage Shifts

[01:02]

• Jakob Emerson notes a notable trend emerging from interviews with leaders of health system-owned health plans.
• Insight: These organizations see opportunities to regain Medicare Advantage membership as large national payers face challenges.
• Five health system-owned plans see the "stumbling" of larger players as an opportunity to boost their own market share.

2. UnitedHealth’s Aggressive Acquisition Strategy

[01:30]

• UnitedHealth’s major acquisition: Amedisys, a home health and hospice provider.
• The deal faced DOJ and state Attorney General challenges but ultimately succeeded.
  • “UnitedHealth just continues to, you know, its acquisition spree and continues to build that empire.” — Jakob Emerson [01:53]
• Post-acquisition, UnitedHealth is now among the largest home health and hospice providers nationwide.

3. Wall Street and Investor Sentiment: The Buffett Effect

[02:20]

• Warren Buffett’s Berkshire Hathaway took a significant stake in UnitedHealth as the company’s stock languished, down 50% this year.
• Scott Becker: “This gave a real shot in the arm to UnitedHealthcare because Warren Buffett and Berkshire are about the most respected of investors.” [02:34]
• Jakob's Analysis:

  • UnitedHealth’s vast, entrenched infrastructure makes it “almost impossible to count them out.”

  • Coverage from Medicare Advantage, Medicaid, commercial insurance, PBM operations, and data dominance through Change Healthcare are cited as strengths.

  • Leadership stability cited: Stephen Hemsley’s return to CEO to “build the company back”.

  • Quote:
    “They hold so many Medicaid contracts with the states. They're the largest commercial insurer, they're one of the largest PBMs. They can see everyone's healthcare data through Change Healthcare … I think counting out or betting against UnitedHealth in the long run is a losing battle.” — Jakob Emerson [03:48]

4. Recent UnitedHealth Physician Group Acquisitions

[05:20]

• Unpublicized physician practice acquisitions:
  • Large gastroenterology group in Pennsylvania and Delaware (acquired January, confirmed via local media).
  • 200-physician group in Kingsport, Tennessee.
• Jakob’s Insight:
  • “There’s nothing really stopping them. There’s no antitrust issues—or even if there is, they seem to be able to come to these settlements … so that they sell off certain clinics in certain markets so they are able to get the bigger deal on the national scale approved.” [06:12]

5. UnitedHealth’s Regulatory Navigation

[06:15]

• UnitedHealth’s legal and policy teams often feature former DOJ antitrust officials, allowing them to structure deals to get regulatory approval.
• “They know how to navigate this convoluted system and how to get these deals over the finish line. And this last week has proven that to be true.” — Jakob Emerson [06:45]

---

Notable Quotes and Memorable Moments

• Scott Becker [00:38]: “Jacob does the best job of covering the payer world as far as I'm concerned in the entire country.”
• Jakob Emerson [01:30]: “They had proposed that back in 2023 so they were able to get it over the finish line and that makes them if not the largest than one of the largest home health and hospice providers in the country.”
• Jakob Emerson [03:48]: “What they've built is, is—exists how it is and like I said, it's not going anywhere … betting against UnitedHealth in the long run is a losing battle.”
• Jakob Emerson [06:45]: “The people … overseeing a lot of these acquisition deals are people that used to work in the DOJ's antitrust division. So they know how to navigate this convoluted system.”

---

Timestamped Highlights

• [01:02] Health system-owned plans aim to regain Medicare Advantage membership.
• [01:30] UnitedHealth’s successful acquisition of Amedisys.
• [02:20] Berkshire Hathaway invests in UnitedHealth; market implications.
• [03:48] Jakob emphasizes UnitedHealth’s unmatched scale and resilience.
• [05:20] UnitedHealth’s covert acquisitions of large physician groups.
• [06:45] UnitedHealth’s regulatory strategy tied to former DOJ officials.

---

Conclusion

Jakob Emerson provides a clear-eyed view of UnitedHealth’s unstoppable expansion and the larger shifts in the U.S. payer landscape. Despite criticism and regulatory hurdles, UnitedHealth’s leadership, acquisition savvy, and vast infrastructure make them a formidable, persistent force—one even market giants like Berkshire Hathaway are betting on.

For industry executives and healthcare observers, the episode underscores both the opportunities for smaller players in the wake of "national stumbles," and the sheer complexity (and force) of UnitedHealth’s empire-building.

---

Transcript

[A]

Exciting things are happening at Beckers Healthcare Stay ahead of industry trends with the new Beckers CFO plus Revenue Cycle Podcast your go to source for insights from top healthcare finance leaders. Tune in wherever you get your podcasts and don't miss the 10th annual Health IT Digital Health RCM Conference happening September 30 to October 3, 2025 in Chicago. Join thousands of executives, engage with industry leaders and explore the future of healthcare innov. Learn more about our upcoming [e-mail] See you there.

[B]

This is Scott Becker with the Becker Healthcare Podcast, thrilled today to be joined by a brilliant leader and journalist. We're joined today by Jacob Emerson. Jacob does the best job of covering the payer world as far as I'm concerned in the entire country. He's always on top of what's going on. Jacob, there's a lot of news right now in the payer space. Give us a sense of what you're watching and what's going on.

[C]

Yeah hey Scott, it's great to talk with you as always. And yeah, it's another day in the pair world and there's just a constant stream of news we're trying to stay on top of across the industry. But two things I wanted to note for you today is a trend that we picked up on based off of some interviews we were doing with the leaders of health system owned health plans. I had chatted with about five of those companies over the last few weeks and one common theme that really stood out in terms of where their seen some opportunity to gain back Medicare Advantage membership as we see some of the larger national players stumble. And then I also thought in terms of the national players, a big deal, probably the largest acquisition this year in this space so far with UnitedHealth acquiring a Medicis home health and hospice provider after the DOJ and some attorney Generals in some states had challenged that deal, the UnitedHealth did pull through. They had proposed that back in 2023 so they were able to get it over the finish line and that makes them if not the largest than one of the largest home health and hospice providers in the country. So UnitedHealth just continues to, you know, its acquisition spree and continues to build that empire.

[B]

Let me ask you about UnitedHealth because in part the most interesting thing I saw this past week was Berkshire Hathaway, the Warren Buffett empire, deciding to add UnitedHealthcare through their list of stocks are investing in. And United of course has been beaten down this year, was down almost 50% this year in Terms of stock price taken out of the chin in a lot of places. But this gave a real shot in the arm to UnitedHealthcare because Warren Buffett and Berkshire are about the most respected of investors. Any thoughts or things you're hearing about that?

[C]

Yeah, I mean I saw that. And to be frank with you, Scott, it didn't really surprise me because I think kind of how we've talked about it in the past that UnitedHealth is so massive and so large in, has its arms in so many parts of the healthcare system at this point in terms of just being so much of our healthcare infrastructure that you know, even when they do stumble, even when the market runs into issues and things like that, they're not going anywhere. They're, they're always going to be, you know, the largest or as of now, they're the largest Medicare Advantage company. They hold so many Medicaid contracts with the states. They're the largest commercial insurer, they're the, one of the largest PBMs. They can see everyone's healthcare data through change Healthcare, you know, they're comprised of 2700 subsidiaries, a lot of those clinical. So they have the largest physician network and ownership there. So I think from, from that perspective it's almost impossible to count them out because you know, what they've built is, it is, it exists how it is and like I said, it's not going anywhere. And so I think counting out or betting against United Health in the long run is a losing battle. Even if they make temporary stumbles because this company, they knows what, they know what they're doing. They're very, you know, they have best people in the world in terms of who they're having run this company. And that's what we've kind of seen. When the last CEO resigned, they brought back the leader, Stephen Hemsley, who built this company into what it is today. And that's what they've indicated through their earnings calls, through their SEC filings, just through everything they've done over this last six months or so, they've really indicated they're not taking this sitting out. They're reorganizing and they're ready to basically build the company back in terms of st price back to exactly what it was. So I think from an investor perspective, you know, it makes sense. You, it's like if there's anybody that's going to be able to build back to what it was, it's, it's United.

[B]

Fascinating. Great even handed take. I can't even tell you much. I appreciate that Jacob so anything else you're watching closely? We've watched United grow again with the medicine. Amazing.

[C]

Yeah.

[B]

I mean, obviously providers don't love the fact that United has grown so much and they certainly don't love the fact that Berkshire is giving United another shot in the arm and strengthening it again. But anything else that's top of mind that you've got an eye on, that particularly is that you're watching closely right.

[C]

Now, not from United's perspective. I mean, that really was the big piece of news this, this last week. We did see some recent news reported from, from local outlets in different parts of the country that they did purchase a very large gastroenterology physician practice in Pennsylvania and Delaware area and one of the largest gastro physician practices in the country. So they, they actually acquired that back in January, kind of like how, how they always do. It wasn't actually ever, you know, publicized. There was no press release, anything like that. But they did confirm it to some local Philadelphia media. So they now have have that area. There was another major physician group, 200 physician group that they purchased down in Tennessee that's based out of Kingsport that they confirmed this month as well. So in terms of that acquisition strategy that I think has been so criticized over these last few years, it's not slowing down and they continue to grow into new areas, new specialties, and there's nothing really stopping them. There's no antitrust issues or even if there is, they seem to be able to come to these settlements with the DOJ and with state attorney generals in the Amedicus case, for example, so that they sell off certain clinics in certain markets so that they are able to get the bigger deal on the national scale approved. So you know, and I think, you know, part of this is what I've mentioned with you on the podcast as well in the past is that you know, the people that, that are at the very top for them in terms of their global public policy individuals, the people overseeing a lot of these acquisition deals are people that used to work in the DOJ's antitrust division. So they know how to, how to navigate this, this convoluted system and how to get these deals over the finish line. And in this last week has, has proven that to be true.

[B]

Absolutely fasting. Jacob, as always, I want to thank you for joining us today on the Vectors Health Care podcast. I always learn something. Love discussing what's going on with United, with you and all the other insurance world issues. You are fantastic. Thank you for joining us today.

[C]

Thank you, Scott.